ctrl K

Terns Pharmaceuticals Inc... (TERN)

NASDAQ: TERN · Real-Time Price · USD

3.56

0.26 (7.88%)

At close: May 01, 2025, 3:59 PM

3.56

-0.14%

Pre-market: May 02, 2025, 05:38 AM EDT

Terns Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	1M	n/a	n/a	n/a
Cost of Revenue	n/a	881K	1.03M	512K	394K	195K	65K
Gross Profit	n/a	-881K	-1.03M	488K	-394K	-195K	-65K
Operating Income	-101.87M	-102.56M	-62.03M	-49.86M	-37.02M	-70.2M	-18.45M
Interest Income	13.29M	12.9M	2.11M	170K	55K	1.2M	332K
Pretax Income	-88.59M	-89.97M	-59.99M	-49.65M	-39.76M	-68.84M	-18.09M
Net Income	-88.85M	-90.21M	-60.34M	-50.16M	-40.57M	-68.82M	-17.71M
Selling & General & Admin	31.76M	39.06M	22.41M	19.55M	9M	8.66M	3.9M
Research & Development	70.11M	63.5M	39.62M	31.31M	28.03M	61.53M	14.55M
Other Expenses	n/a	n/a	-68K	40K	-2.79M	154K	38K
Operating Expenses	101.87M	102.56M	62.03M	50.86M	37.02M	70.2M	18.45M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	102.56M	62.03M	50.86M	37.02M	70.2M	18.45M
Income Tax Expense	260K	239K	358K	508K	813K	-20K	-67K
Shares Outstanding (Basic)	79.51M	71.26M	36.03M	25.27M	25.13M	25.1M	23.97M
Shares Outstanding (Diluted)	79.51M	71.26M	36.03M	25.27M	25.13M	25.1M	23.97M
EPS (Basic)	-1.12	-1.27	-1.67	-1.98	-1.61	-2.74	-0.74
EPS (Diluted)	-1.12	-1.27	-1.67	-1.98	-1.61	-2.74	-0.74
EBITDA	-87.7M	-102.27M	-58.95M	-49.35M	-36.63M	-35M	-18.39M
EBIT	n/a	-102.56M	-62.03M	-49.86M	-37.02M	-68.84M	-18.45M
Depreciation & Amortization	n/a	292K	1.03M	512K	394K	195K	65K